Safety aspects of iodinated contrast media related to their physicochemical properties: A pharmacoepidemiology study in two Tuscany hospitals(494 views) Lapi F, Cecchi E, Pedone C, Attanasio F, Banchelli G, Vannacci A, Di Pirro M, Moschini M, Berni V, Matucci R, Cini E, Scalia A, Tendi E, Mugelli A
Tuscan Regional Centre of Pharmacovigilance, Department of Pharmacology, University of Florence, Viale G. Pieraccini n 6, Florence 50139, Italy
Department of Geriatric Medicine, University Campus Bio-Medico, Rome, Italy
Hospital Pharmacy, ASL3 Hospital, Pistoia, Italy
References: Lasser, E.C., Anaphylaxis (2004) Novartis Found Symp, 257, pp. 211-22
Sangiorgi, G., Mezzi di contrasto e safety renale-cardiaca nel laboratorio di emodinamica (2003) Emodinamica, 89, pp. 990-992. , 9
Katayama, H., Yamaguchi, K., Kozuka, T., Takashima, T., Seez, P., Matsuura, K., Adverse reactions to ionic and nonionic contrast media. a report from the Japanese Committee on the Safety of Contrast Media (1990) Radiology, 175, pp. 621-628. , 3
Almen, T., The etiology of contrast medium reactions (1994) Invest Radiol, 29, pp. 37-S45. , 1
Brockow, K., Christiansen, C., Kanny, G., Clement, O., Barbaud, A., Bircher, A., Dewachter, P., Pichler, W.J., Management of hypersensitivity reactions to iodinated contrast media (2005) Allergy, 60, pp. 150-158. , 2
Meth, M.J., Maibach, H.I., Current understanding of contrast media reactions and implications for clinical management (2006) Drug Safety, 29, pp. 133-141. , 2
Schild, H.H., Kuhl, C.K., Hubner-Steiner, U., Bohm, I., Speck, U., Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: A prospective randomized controlled trial (2006) Radiology, 240, pp. 56-64. , 1
Sutton, A.G., Finn, P., Grech, E.D., Hall, J.A., Stewart, M.J., Davies, A., De Belder, M.A., Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization (2001) Am Heart J, 141, pp. 677-683. , 4
Idee, J.M., Pines, E., Prigent, P., Corot, C., Allergy-like reactions to iodinated contrast agents. a critical analysis (2005) Fundam Clin Pharmacol, 19, pp. 263-281. , 3
Morcos, S.K., Review article: Effects of radiographic contrast media on the lung (2003) Br J Radiol, 76, pp. 290-295. , 905
Webb, J.A., Stacul, F., Thomsen, H.S., Morcos, S.K., Late adverse reactions to intravascular iodinated contrast media (2003) Eur Radiol, 13, pp. 181-184. , 1
Thomsen, H.S., European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media (2006) Eur J Radiol, 60, pp. 307-313. , 3
Mortelé, K.J., Oliva, M.R., Ondategui, S., Ros, P.R., Silverman, S.G., Universal use of nonionic iodinated contrast medium for CT: Evaluation of safety in a large urban teaching hospital (2005) AJR Am J Roentgenol, 184, pp. 31-34. , 1
Dawson, P., Adverse reactions to intravascular contrast agents (2006) BMJ, 333, pp. 663-664. , 7570
Tramèr, M.R., Von Elm, E., Loubeyre, P., Hauser, C., Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: Systematic review (2006) BMJ, 333, pp. 675-680. , 7570
Olsson, S., The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts (1998) Drug Safety, 19, pp. 1-10. , 1
Pahor, M., Chrischilles, E.A., Guralnik, J.M., Brown, S.L., Wallace, R.B., Carbonin, P., Drug data coding and analysis in epidemiologic studies (1994) Eur J Epidemiol, 10, pp. 405-411. , 4
(1980) PHS-HCFA International Classification Diseases, 9th Revision, , Public Health Service-Health Care Financing Administration, Washington DC
Naranjo, C.A., Busto, U., Sellers, E.M., Sandor, P., Ruiz, I., Roberts, E.A., Janecek, E., Greenblatt, D.J., A method for estimating the probability of adverse drug reactions (1981) Clin Pharmacol Ther, 30, pp. 239-245. , 2
Morcos, S.K., Thomsen, H.S., Webb, J.A., Prevention of generalized reactions to contrast media: A consensus report and guidelines (2001) Eur Radiol, 11, pp. 1720-1728. , 9
Mikkonen, R., Kontkanen, T., Kivisaari, L., Acute and late adverse reactions to low-osmolal contrast media (1995) Acta Radiol, 36, pp. 72-76. , 1
Hosoya, T., Yamaguchi, K., Akutsu, T., Mitsuhashi, Y., Kondo, S., Sugai, Y., Adachi, M., Delayed adverse reactions to iodinated contrast media and their risk factors (2000) Radiat Med, 18, pp. 39-45. , 1
Yoshikawa, H., Late adverse reactions to nonionic contrast media (1992) Radiology, 183, pp. 737-740. , 3
Esplugas, E., Cequier, A., Gomez-Hospital, J.A., Del Blanco, B.G., Jara, F., Comparative tolerability of contrast media used for coronary interventions (2002) Drug Safety, 25, pp. 1079-1098. , 15
Munechika, H., Hiramatsu, Y., Kudo, S., Sugimura, K., Hamada, C., Yamaguchi, K., Katayama, H., A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography (2003) Eur Radiol, 13, pp. 185-194. , 1
Lasser, E.C., The radiocontrast molecule in anaphylaxis: A surprising antigen (2004) Novartis Found Symp, 257, pp. 211-224. , discussion
Radhakrishnan, S., Manoharan, S., Fleet, M., Repeat survey of current practice regarding corticosteroid prophylaxis for patients at increased risk of adverse reaction to intravascular contrast agents (2005) Clin Radiol, 60, pp. 58-63. , 1
Drici, M.D., Clement, N., Is gender a risk factor for adverse drug reactions? the example of drug-induced long QT syndrome (2001) Drug Safety, 24, pp. 575-585. , 8
Lasser, E.C., Gender risk for anaphylactoid reactions to contrast material (1995) J Allergy Clin Immunol, 96, pp. 1019-1020. , 6
Ansell, G., Tweedie, M.C., West, C.R., Evans, P., Couch, L., The current status of reactions to intravenous contrast media (1980) Invest Radiol, 15, pp. 32-S39. , 6
Leone, R., Conforti, A., Venegoni, M., Motola, D., Moretti, U., Meneghelli, I., Cocci, A., Velo, G., Drug-induced anaphylaxis: Case/non-case study based on an italian pharmacovigilance database (2005) Drug Safety, 28, pp. 547-556. , 6
Benahmed, S., Picot, M.C., Dumas, F., Demoly, P., Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions (2005) Arch Intern Med, 165, pp. 1500-1505. , 13
MacEdo, A.F., Marques, F.B., Ribeiro, C.F., Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs? (2006) Drug Safety, 29, pp. 697-702. , 8
Crowne, D.P., Marlowe, D., A new scale of social desirability independent of psychopathology (1960) J Consult Psychol, 24, pp. 349-354
Marlowe, D., Crowne, D.P., Social desirability and response to perceived situational demands (1961) J Consult Psychol, 25, pp. 109-115
Lasser, E. C., Anaphylaxis (2004) Novartis Found Symp, 257, pp. 211-22
Persson, P. B., Editorial: Contrast medium-induced nephropathy (2005) Nephrol Dial Transplant, 20, p. 1. , Suppl 1
Meth, M. J., Maibach, H. I., Current understanding of contrast media reactions and implications for clinical management (2006) Drug Safety, 29, pp. 133-141. , 2
Schild, H. H., Kuhl, C. K., Hubner-Steiner, U., Bohm, I., Speck, U., Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: A prospective randomized controlled trial (2006) Radiology, 240, pp. 56-64. , 1
Sutton, A. G., Finn, P., Grech, E. D., Hall, J. A., Stewart, M. J., Davies, A., De Belder, M. A., Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization (2001) Am Heart J, 141, pp. 677-683. , 4
Idee, J. M., Pines, E., Prigent, P., Corot, C., Allergy-like reactions to iodinated contrast agents. a critical analysis (2005) Fundam Clin Pharmacol, 19, pp. 263-281. , 3
Morcos, S. K., Review article: Effects of radiographic contrast media on the lung (2003) Br J Radiol, 76, pp. 290-295. , 905
Webb, J. A., Stacul, F., Thomsen, H. S., Morcos, S. K., Late adverse reactions to intravascular iodinated contrast media (2003) Eur Radiol, 13, pp. 181-184. , 1
Thomsen, H. S., European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media (2006) Eur J Radiol, 60, pp. 307-313. , 3
Mortel, K. J., Oliva, M. R., Ondategui, S., Ros, P. R., Silverman, S. G., Universal use of nonionic iodinated contrast medium for CT: Evaluation of safety in a large urban teaching hospital (2005) AJR Am J Roentgenol, 184, pp. 31-34. , 1
Tram r, M. R., Von Elm, E., Loubeyre, P., Hauser, C., Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: Systematic review (2006) BMJ, 333, pp. 675-680. , 7570
(1980) PHS-HCFA International Classification Diseases, 9th Revision, , Public Health Service-Health Care Financing Administration, Washington DC
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Greenblatt, D. J., A method for estimating the probability of adverse drug reactions (1981) Clin Pharmacol Ther, 30, pp. 239-245. , 2
Morcos, S. K., Thomsen, H. S., Webb, J. A., Prevention of generalized reactions to contrast media: A consensus report and guidelines (2001) Eur Radiol, 11, pp. 1720-1728. , 9
Lasser, E. C., The radiocontrast molecule in anaphylaxis: A surprising antigen (2004) Novartis Found Symp, 257, pp. 211-224. , discussion
Drici, M. D., Clement, N., Is gender a risk factor for adverse drug reactions? the example of drug-induced long QT syndrome (2001) Drug Safety, 24, pp. 575-585. , 8
Lasser, E. C., Gender risk for anaphylactoid reactions to contrast material (1995) J Allergy Clin Immunol, 96, pp. 1019-1020. , 6
MacEdo, A. F., Marques, F. B., Ribeiro, C. F., Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs? (2006) Drug Safety, 29, pp. 697-702. , 8
Crowne, D. P., Marlowe, D., A new scale of social desirability independent of psychopathology (1960) J Consult Psychol, 24, pp. 349-354
Safety aspects of iodinated contrast media related to their physicochemical properties: A pharmacoepidemiology study in two Tuscany hospitals